Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07719348
What this trial is testing

Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome Acute Myeloid Leukemia
Servier 64
Testing effectiveness (Phase 2)Study completedNCT00406978
What this trial is testing

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Silvio Aime 24
Not applicableUnknownNCT03667885
What this trial is testing

Non-Invasive Diagnostics of Small Renal Masses

Who this might be right for
Renal Cell CarcinomaRenal Tumor
Odense University Hospital 160
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT00064038
What this trial is testing

S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
SWOG Cancer Research Network 198
Not applicableLooking for participantsNCT06497738
What this trial is testing

A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 112
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT03374085
What this trial is testing

A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
Celgene 200
Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)UnknownNCT05951855
What this trial is testing

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia (Relapsed/Refractory)
The First Affiliated Hospital of Soochow University 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT06742138
What this trial is testing

To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 284
Not applicableUnknownNCT05174338
What this trial is testing

Cardiac Amyloidosis Registry Study

Who this might be right for
Amyloidosis, Immunoglobulin Light-chain
Cedars-Sinai Medical Center 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151326
What this trial is testing

Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 60
Not applicableStudy completedNCT04595838
What this trial is testing

A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis

Who this might be right for
Oral Mucositis
Chemo Mouthpiece 176
Testing effectiveness (Phase 2)Temporarily pausedNCT04824352
What this trial is testing

Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, Drug
Peking University People's Hospital 44
Large-scale testing (Phase 3)Study completedNCT00928486
What this trial is testing

A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 25
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Not applicableStudy completedNCT01487031
What this trial is testing

Music Therapy on Nausea and Pain for Autologous Stem Cell

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Lymphoma
Case Comprehensive Cancer Center 108
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Next Page